Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
Acomhal Research develops a peptide drug designed to target and eliminate cancer stem cells, preventing tumor recurrence and metastasis across multiple cancer types including glioblastoma, breast cancer, and others. The company operates in the biotech sector, focusing on novel therapeutics for drug-resistant cancers.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Actinium is developing targeted radiotherapy treatments using Actinium-225 and related isotopes for oncology indications including prostate cancer, non-small cell lung cancer, breast cancer, and acute myeloid leukemia. The company's lead candidates include ATNM-400 for solid tumors and Actimab-A for blood malignancies.
0 investors
0 investors
Acuitive Technologies is an orthopedic medical device company developing products using citrate-based biodegradable biomaterials for regenerative applications, including foot and ankle surgery. Its team consists of veterans of the orthopedic industry drawn from companies such as J&J, Zimmer, Stryker, and MAKO.
0 investors
0 investors
0 investors
0 investors
0 investors
Adapt Biotechnologies develops the BRiTE platform, a bispecific antibody technology designed to treat brain tumors and intracerebral malignancies by activating T cells to target and destroy glioma cells. The platform combines manipulated T cells with bispecific antibodies to deliver targeted therapy to brain tissue.
0 investors
0 investors
0 investors
Adial Pharmaceuticals is a biopharmaceutical company developing treatments for addiction and inflammatory disease, including AT177, a colon-targeted AhR agonist for ulcerative colitis, and AD04, a genetically targeted serotonin-3 receptor antagonist in Phase 3 trials for Alcohol Use Disorder. It is publicly listed on Nasdaq under the ticker ADIL.
0 investors
ADiTx Therapeutics develops therapeutic and diagnostic products focused on immune modulation and early cancer detection through its subsidiaries. The company commercializes an apoptotic DNA immunotherapy platform designed to induce immune tolerance for autoimmune diseases and organ transplant rejection, and operates a molecular diagnostics business developing mitochondrial DNA-based biomarker tests for cancer screening and other diseases.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors